bicalutamide has been researched along with Heart Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akdas, A; Bolla, M; Collette, L; de Reijke, TM; Gez, E; Kariakine, O; Kil, P; Mauer, ME; Musat, E; Oddens, J; PiƩrart, M; Poortmans, PM; Soete, G; Van den Bergh, AC; van der Steen-Banasik, EM; Van Tienhoven, G | 1 |
1 trial(s) available for bicalutamide and Heart Diseases
Article | Year |
---|---|
Duration of androgen suppression in the treatment of prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Heart Diseases; Humans; Male; Middle Aged; Nitriles; Proportional Hazards Models; Prostatic Neoplasms; Quality of Life; Radiotherapy, Conformal; Tosyl Compounds; Treatment Failure | 2009 |